Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of Belotero® Intense Lidocaine for Lip Augmentation

NCT: NCT05773066 · COMPLETED

NCT IDNCT05773066
StatusCOMPLETED
Start Date2023-03-03
Completion2024-09-26
SponsorMerz North America, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to demonstrate the safety and effectiveness of Belotero Intense Lidocaine (BIL) for lip augmentation in subjects with upper and/or lower lip deficit.

Frequently Asked Questions

What is A Study of Belotero® Intense Lidocaine for Lip Augmentation?

A Study of Belotero® Intense Lidocaine for Lip Augmentation is a clinical trial registered under NCT05773066. Current status: COMPLETED.

What is the status of NCT05773066?

The current status of NCT05773066 (A Study of Belotero® Intense Lidocaine for Lip Augmentation) is: COMPLETED.

When did A Study of Belotero® Intense Lidocaine for Lip Augmentation start?

A Study of Belotero® Intense Lidocaine for Lip Augmentation started on 2023-03-03.

Related Devices

K172689DESCRIBE PFD PatchMerz North America, Inc. PMA P040047AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USEMerz North America, Inc. PMA P050037Implant, dermal, for aesthetic useMerz North America, Inc. PMA P050052Implant, dermal, for aesthetic useMerz North America, Inc. PMA P090016Implant, dermal, for aesthetic useMerz North America, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑